MELBOURNE, Australia, Feb. 26 /PRNewswire/ -- Bionomics Limited today announced the initiation of treatment for the first patient in the Phase I trial of its anti-cancer drug, BNC105. The BNC105 Phase I clinical trial involves treatment of patients with advanced cancer.

MELBOURNE, Australia, Aug. 28 /PRNewswire/ -- Cancer Therapeutics CRC Pty Ltd (CTx) has commenced operations as one of the largest public/private partnerships of its type in the world.

ADELAIDE, Australia, Nov. 2 /PRNewswire-FirstCall/ -- Bionomics (ASX: BNO, BNOOA; US OTC: BMICY) announced today that it has licensed two genetic tests for the diagnosis of epilepsy to Laboratory Corporation of America(R) Holdings (LabCorp(R)) .